Evidence map›Paper›PMID 28223516›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Targeting human Mas-related G protein-coupled receptor X1 to inhibit persistent pain.

Zhe Li, Pang-Yen Tseng, Vinod Tiwari, Qian Xu, Shao-Qiu He, Yan Wang, Qin Zheng, Liang Han, Zhiping Wu, Anna L Blobaum and 12 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 83 citations in OpenAlex.

  1. An Itch Receptor Drives Melanoma.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Endosomal MrGPRX1 signaling sensitizes TRPV1 to enhance itch.Frontiers in molecular neuroscience · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Targeting sensory neuron GPCRs for peripheral neuropathic pain.Trends in pharmacological sciences · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 2 countries.

Zhe LiThe Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Pang-Yen TsengThe Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Vinod TiwariDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Qian XuThe Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Shao-Qiu HeDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Yan WangThe Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Qin ZhengThe Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Liang HanThe Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Zhiping WuDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105.
Anna L BlobaumDepartment of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Specialized Chemistry Center, Vanderbilt University Medical Center, Nashville, TN 37232.
Yiyuan CuiThe State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Vineeta TiwariDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Shuohao SunThe Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Yingying ChengThe Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Julie H Y Huang-LionnetDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Yixun GengThe Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Bo XiaoThe State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Junmin PengDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105.
Corey HopkinsDepartment of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Specialized Chemistry Center, Vanderbilt University Medical Center, Nashville, TN 37232.
Srinivasa N RajaDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Yun GuanDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205; xdong2@jhmi.edu yguan1@jhmi.edu.
Xinzhong DongThe Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205; xdong2@jhmi.edu yguan1@jhmi.edu.
Johns Hopkins University · USJohns Hopkins Medicine · USState Key Laboratory of BiotherapySt. Jude Children's Research Hospital · USVanderbilt University Medical Center · USHoward Hughes Medical Institute · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Murine Mutagenesis CoreP30NS050274 · NINDS · JOHNS HOPKINS UNIVERSITY · PI KOLODKIN, ALEX L · 2005 to 2020
$10.9M
Functional analysis of the Mrg receptor family in pain sensationR01NS054791 · NINDS · JOHNS HOPKINS UNIVERSITY · PI DONG, XINZHONG · 2007 to 2020
$5.0M
Neuronal subtype-specific plasticity in the acute to chronic pain transitionR01DE022750 · NIDCR · JOHNS HOPKINS UNIVERSITY · PI CATERINA, MICHAEL J, DONG, XINZHONG · 2012 to 2016
$3.5M
Mrgs as New Target for the Treatment of Neuropathic PainR01NS070814 · NINDS · JOHNS HOPKINS UNIVERSITY · PI GUAN, YUN · 2011 to 2020
$3.2M
RNA splicing dysfunction in Alzheimer's diseaseR01AG047928 · NIA · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI PENG, JUNMIN · 2015 to 2019
$1.8M
Molecular and Cellular Mechanisms of Itch SensationR00NS087088 · NINDS · GEORGIA INSTITUTE OF TECHNOLOGY · PI HAN, LIANG · 2016 to 2018
$739k
Developing Novel Direct Current Stimulation Technology for Safe Precision Pain TreatmentR21NS099879 · NINDS · JOHNS HOPKINS UNIVERSITY · PI GUAN, YUN · 2016 to 2017
$449k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA021765NIA NIH HHS R01 AG047928NIDCR NIH HHS R01 DE022750NINDS NIH HHS P30 NS050274NINDS NIH HHS R00 NS087088NINDS NIH HHS R01 NS054791NINDS NIH HHS R01 NS070814NINDS NIH HHS R21 NS099879
6 · The paper itself

Abstract

Human Mas-related G protein-coupled receptor X1 (MRGPRX1) is a promising target for pain inhibition, mainly because of its restricted expression in nociceptors within the peripheral nervous system. However, constrained by species differences across

Indexed as

Disease Models, AnimalAllosteric RegulationAnalgesicsAnimalsBenzamidesCalcium Channel BlockersCalcium ChannelsCattleChronic PainGene ExpressionHumansMaleMiceMice, TransgenicNociceptionPeptide FragmentsAnalgesicsBenzamidesbovine adrenal medulla 8-22Calcium Channel BlockersCalcium Channelsmas-related gene-X1 receptor, humanML382 compoundPeptide FragmentsReceptors, G-Protein-CoupledSulfonamidesDRG neuronsGPCRMrgprX1painpositive allosteric modulator

Identifiers

PMID28223516
PMCPMC5347560
OpenAlexW2589953838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.